{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T08:16:35Z","timestamp":1787991395732,"version":"build-2784847793"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T00:00:00Z","timestamp":1783209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Obesity Pillars"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.obpill.2026.100295","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T23:18:45Z","timestamp":1783379925000},"page":"100295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Nutritional deficiencies should be systematically assessed as potential adverse effects in incretin-based obesity therapies"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6733-4801","authenticated-orcid":false,"given":"Jean-Philippe","family":"Drouin-Chartier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Lessard-Lord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.obpill.2026.100295_bib1","article-title":"Nutritional status with tirzepatide in obesity: a post hoc analysis of the SURMOUNT-1-4 randomized clinical trials","volume":"17","author":"Almandoz","year":"2026","journal-title":"Obes Pillars"},{"key":"10.1016\/j.obpill.2026.100295_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.965376","article-title":"Prevalence, trend, and predictor analyses of vitamin D deficiency in the US population, 2001-2018","volume":"9","author":"Cui","year":"2022","journal-title":"Front Nutr"},{"issue":"4","key":"10.1016\/j.obpill.2026.100295_bib3","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3945\/ajcn.115.120873","article-title":"Vitamin D deficiency in Europe: pandemic?12","volume":"103","author":"Cashman","year":"2016","journal-title":"Am J Clin Nutr"},{"issue":"9","key":"10.1016\/j.obpill.2026.100295_bib5","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/oby.24067","article-title":"Nutritional considerations with antiobesity medications","volume":"32","author":"Almandoz","year":"2024","journal-title":"Obesity"},{"issue":"3","key":"10.1016\/j.obpill.2026.100295_bib6","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.obpill.2026.100295_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.obpill.2025.100186","article-title":"Nutritional deficiencies and muscle loss in adults with type 2 diabetes using GLP-1 receptor agonists: a retrospective observational study","volume":"15","author":"Scott Butsch","year":"2025","journal-title":"Obesity Pillars"},{"issue":"3","key":"10.1016\/j.obpill.2026.100295_bib8","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/dom.14280","article-title":"The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity","volume":"23","author":"Friedrichsen","year":"2021","journal-title":"Diabetes Obes Metabol"},{"issue":"5","key":"10.1016\/j.obpill.2026.100295_bib9","doi-asserted-by":"crossref","first-page":"998","DOI":"10.2337\/dc22-1710","article-title":"Tirzepatide reduces appetite, energy intake, and fat mass in people with type 2 diabetes","volume":"46","author":"Heise","year":"2023","journal-title":"Diabetes Care"},{"issue":"7","key":"10.1016\/j.obpill.2026.100295_bib10","doi-asserted-by":"crossref","first-page":"841","DOI":"10.7326\/M24-0190","article-title":"Trends in diet quality among U.S. adults from 1999 to 2020 by race, ethnicity, and socioeconomic disadvantage","volume":"177","author":"Liu","year":"2024","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.obpill.2026.100295_bib11","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1093\/ajcn\/nqab143","article-title":"Nutrient intakes of Canadian adults: results from the canadian community health survey (CCHS)-2015 public use microdata file","volume":"114","author":"Ahmed","year":"2021","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"10.1016\/j.obpill.2026.100295_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/nu15030637","article-title":"Canadians adults fail their dietary quality examination twice","volume":"15","author":"Ngueta","year":"2023","journal-title":"Nutrients"}],"container-title":["Obesity Pillars"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667368126000513?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667368126000513?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T07:33:14Z","timestamp":1787988794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667368126000513"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":11,"alternative-id":["S2667368126000513"],"URL":"https:\/\/doi.org\/10.1016\/j.obpill.2026.100295","relation":{},"ISSN":["2667-3681"],"issn-type":[{"value":"2667-3681","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nutritional deficiencies should be systematically assessed as potential adverse effects in incretin-based obesity therapies","name":"articletitle","label":"Article Title"},{"value":"Obesity Pillars","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.obpill.2026.100295","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Obesity Medicine Association.","name":"copyright","label":"Copyright"}],"article-number":"100295"}}